Do analysts prefer VMD or WGS?

GeneDx has a consensus target price of $87.43, indicating a potential upside of 47.93%. Given GeneDx's stronger consensus rating and higher possible upside, analysts clearly believe GeneDx is more favorable than Viemed Healthcare. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Viemed Healthcare 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 GeneDx 2 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.56

Does the media favor VMD or WGS?

In the previous week, GeneDx had 31 more articles in the media than Viemed Healthcare. MarketBeat recorded 33 mentions for GeneDx and 2 mentions for Viemed Healthcare. Viemed Healthcare's average media sentiment score of 0.39 beat GeneDx's score of 0.26 indicating that Viemed Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Viemed Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral GeneDx 3 Very Positive mention(s) 0 Positive mention(s) 29 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend VMD or TDOC?

Teladoc Health has a consensus target price of $7.57, suggesting a potential downside of 13.20%. Given Teladoc Health's stronger consensus rating and higher possible upside, analysts clearly believe Teladoc Health is more favorable than Viemed Healthcare. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Viemed Healthcare 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Teladoc Health 1 Sell rating(s) 10 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.25

Does the media prefer VMD or TDOC?

In the previous week, Teladoc Health had 8 more articles in the media than Viemed Healthcare. MarketBeat recorded 10 mentions for Teladoc Health and 2 mentions for Viemed Healthcare. Teladoc Health's average media sentiment score of 0.72 beat Viemed Healthcare's score of 0.39 indicating that Teladoc Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Viemed Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Teladoc Health 2 Very Positive mention(s) 5 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate FTRE or VMD?

Fortrea currently has a consensus target price of $17.75, suggesting a potential downside of 9.07%. Given Fortrea's stronger consensus rating and higher possible upside, equities analysts plainly believe Fortrea is more favorable than Viemed Healthcare. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fortrea 1 Sell rating(s) 4 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.55 Viemed Healthcare 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media prefer FTRE or VMD?

In the previous week, Fortrea had 4 more articles in the media than Viemed Healthcare. MarketBeat recorded 6 mentions for Fortrea and 2 mentions for Viemed Healthcare. Fortrea's average media sentiment score of 0.54 beat Viemed Healthcare's score of 0.39 indicating that Fortrea is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fortrea 0 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Viemed Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend INNV or VMD?

InnovAge presently has a consensus price target of $7.00, suggesting a potential downside of 39.45%. Given InnovAge's higher probable upside, analysts clearly believe InnovAge is more favorable than Viemed Healthcare. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InnovAge 2 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.33 Viemed Healthcare 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media refer more to INNV or VMD?

In the previous week, InnovAge had 2 more articles in the media than Viemed Healthcare. MarketBeat recorded 4 mentions for InnovAge and 2 mentions for Viemed Healthcare. InnovAge's average media sentiment score of 0.86 beat Viemed Healthcare's score of 0.39 indicating that InnovAge is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InnovAge 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Viemed Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate ARDT or VMD?

Ardent Health presently has a consensus price target of $14.04, suggesting a potential upside of 32.47%. Given Ardent Health's stronger consensus rating and higher probable upside, equities analysts clearly believe Ardent Health is more favorable than Viemed Healthcare. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ardent Health 2 Sell rating(s) 5 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.36 Viemed Healthcare 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media refer more to ARDT or VMD?

In the previous week, Viemed Healthcare had 1 more articles in the media than Ardent Health. MarketBeat recorded 2 mentions for Viemed Healthcare and 1 mentions for Ardent Health. Ardent Health's average media sentiment score of 1.01 beat Viemed Healthcare's score of 0.39 indicating that Ardent Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ardent Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Viemed Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Viemed Healthcare (VMD) Competitors

$11.77 +0.10 (+0.86%)

Closing price 07/24/2026 04:00 PM Eastern

Extended Trading

$11.76 -0.01 (-0.13%)

As of 07/24/2026 07:34 PM Eastern

Compare

VMD vs. WGS, TDOC, FTRE, INNV, and ARDT

Should you buy Viemed Healthcare stock or one of its competitors? MarketBeat compares Viemed Healthcare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Viemed Healthcare include GeneDx (WGS), Teladoc Health (TDOC), Fortrea (FTRE), InnovAge (INNV), and Ardent Health (ARDT). These companies are all part of the "healthcare" industry.

How does Viemed Healthcare compare to GeneDx?

Viemed Healthcare (NASDAQ:VMD) and GeneDx (NASDAQ:WGS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, dividends, risk, earnings, media sentiment and valuation.

Viemed Healthcare has a beta of 1.1, meaning that its stock price is 10% more volatile than the broader market. Comparatively, GeneDx has a beta of 1.9, meaning that its stock price is 90% more volatile than the broader market.

74.2% of Viemed Healthcare shares are held by institutional investors. Comparatively, 61.7% of GeneDx shares are held by institutional investors. 20.6% of Viemed Healthcare shares are held by company insiders. Comparatively, 25.2% of GeneDx shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

GeneDx has a consensus target price of $87.43, indicating a potential upside of 47.93%. Given GeneDx's stronger consensus rating and higher possible upside, analysts clearly believe GeneDx is more favorable than Viemed Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Viemed Healthcare	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
GeneDx	2 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.56

Viemed Healthcare has a net margin of 5.20% compared to GeneDx's net margin of -17.58%. Viemed Healthcare's return on equity of 10.52% beat GeneDx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Viemed Healthcare	5.20%	10.52%	7.60%
GeneDx	-17.58%	9.15%	5.21%

In the previous week, GeneDx had 31 more articles in the media than Viemed Healthcare. MarketBeat recorded 33 mentions for GeneDx and 2 mentions for Viemed Healthcare. Viemed Healthcare's average media sentiment score of 0.39 beat GeneDx's score of 0.26 indicating that Viemed Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Viemed Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
GeneDx	3 Very Positive mention(s)	0 Positive mention(s)	29 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Viemed Healthcare has higher earnings, but lower revenue than GeneDx. GeneDx is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Viemed Healthcare	$270.28M	1.67	$14.93M	$0.37	31.81
GeneDx	$427.54M	4.10	-$21.02M	-$2.68	N/A

Summary

Viemed Healthcare and GeneDx tied by winning 8 of the 16 factors compared between the two stocks.

How does Viemed Healthcare compare to Teladoc Health?

Viemed Healthcare (NASDAQ:VMD) and Teladoc Health (NYSE:TDOC) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, analyst recommendations, earnings, profitability, dividends and valuation.

Viemed Healthcare has higher earnings, but lower revenue than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Viemed Healthcare	$270.28M	1.67	$14.93M	$0.37	31.81
Teladoc Health	$2.53B	0.62	-$200.32M	-$0.97	N/A

In the previous week, Teladoc Health had 8 more articles in the media than Viemed Healthcare. MarketBeat recorded 10 mentions for Teladoc Health and 2 mentions for Viemed Healthcare. Teladoc Health's average media sentiment score of 0.72 beat Viemed Healthcare's score of 0.39 indicating that Teladoc Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Viemed Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Teladoc Health	2 Very Positive mention(s)	5 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Teladoc Health has a consensus target price of $7.57, suggesting a potential downside of 13.20%. Given Teladoc Health's stronger consensus rating and higher possible upside, analysts clearly believe Teladoc Health is more favorable than Viemed Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Viemed Healthcare	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Teladoc Health	1 Sell rating(s)	10 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25

74.2% of Viemed Healthcare shares are owned by institutional investors. Comparatively, 76.8% of Teladoc Health shares are owned by institutional investors. 20.6% of Viemed Healthcare shares are owned by company insiders. Comparatively, 0.7% of Teladoc Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Viemed Healthcare has a net margin of 5.20% compared to Teladoc Health's net margin of -6.81%. Viemed Healthcare's return on equity of 10.52% beat Teladoc Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Viemed Healthcare	5.20%	10.52%	7.60%
Teladoc Health	-6.81%	-11.45%	-5.54%

Viemed Healthcare has a beta of 1.1, indicating that its share price is 10% more volatile than the broader market. Comparatively, Teladoc Health has a beta of 2.1, indicating that its share price is 110% more volatile than the broader market.

Summary

Viemed Healthcare and Teladoc Health tied by winning 8 of the 16 factors compared between the two stocks.

How does Viemed Healthcare compare to Fortrea?

Fortrea (NASDAQ:FTRE) and Viemed Healthcare (NASDAQ:VMD) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, risk, analyst recommendations, institutional ownership, valuation and earnings.

Viemed Healthcare has a net margin of 5.20% compared to Fortrea's net margin of -16.50%. Viemed Healthcare's return on equity of 10.52% beat Fortrea's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fortrea	-16.50%	9.51%	1.96%
Viemed Healthcare	5.20%	10.52%	7.60%

Fortrea currently has a consensus target price of $17.75, suggesting a potential downside of 9.07%. Given Fortrea's stronger consensus rating and higher possible upside, equities analysts plainly believe Fortrea is more favorable than Viemed Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fortrea	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.55
Viemed Healthcare	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

74.2% of Viemed Healthcare shares are held by institutional investors. 0.7% of Fortrea shares are held by insiders. Comparatively, 20.6% of Viemed Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Viemed Healthcare has lower revenue, but higher earnings than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fortrea	$2.72B	0.68	-$986.20M	-$4.91	N/A
Viemed Healthcare	$270.28M	1.67	$14.93M	$0.37	31.81

Fortrea has a beta of 2.03, suggesting that its stock price is 103% more volatile than the broader market. Comparatively, Viemed Healthcare has a beta of 1.1, suggesting that its stock price is 10% more volatile than the broader market.

In the previous week, Fortrea had 4 more articles in the media than Viemed Healthcare. MarketBeat recorded 6 mentions for Fortrea and 2 mentions for Viemed Healthcare. Fortrea's average media sentiment score of 0.54 beat Viemed Healthcare's score of 0.39 indicating that Fortrea is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fortrea	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Viemed Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Viemed Healthcare beats Fortrea on 9 of the 17 factors compared between the two stocks.

How does Viemed Healthcare compare to InnovAge?

InnovAge (NASDAQ:INNV) and Viemed Healthcare (NASDAQ:VMD) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.

InnovAge presently has a consensus price target of $7.00, suggesting a potential downside of 39.45%. Given InnovAge's higher probable upside, analysts clearly believe InnovAge is more favorable than Viemed Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InnovAge	2 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.33
Viemed Healthcare	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Viemed Healthcare has lower revenue, but higher earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InnovAge	$853.70M	1.84	-$30.31M	-$0.09	N/A
Viemed Healthcare	$270.28M	1.67	$14.93M	$0.37	31.81

InnovAge has a beta of 0.36, indicating that its stock price is 64% less volatile than the broader market. Comparatively, Viemed Healthcare has a beta of 1.1, indicating that its stock price is 10% more volatile than the broader market.

In the previous week, InnovAge had 2 more articles in the media than Viemed Healthcare. MarketBeat recorded 4 mentions for InnovAge and 2 mentions for Viemed Healthcare. InnovAge's average media sentiment score of 0.86 beat Viemed Healthcare's score of 0.39 indicating that InnovAge is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InnovAge	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Viemed Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

12.3% of InnovAge shares are owned by institutional investors. Comparatively, 74.2% of Viemed Healthcare shares are owned by institutional investors. 1.0% of InnovAge shares are owned by insiders. Comparatively, 20.6% of Viemed Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Viemed Healthcare has a net margin of 5.20% compared to InnovAge's net margin of -1.22%. Viemed Healthcare's return on equity of 10.52% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InnovAge	-1.22%	-4.73%	-2.20%
Viemed Healthcare	5.20%	10.52%	7.60%

Summary

Viemed Healthcare beats InnovAge on 10 of the 15 factors compared between the two stocks.

How does Viemed Healthcare compare to Ardent Health?

Ardent Health (NYSE:ARDT) and Viemed Healthcare (NASDAQ:VMD) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, profitability, risk and institutional ownership.

Viemed Healthcare has a net margin of 5.20% compared to Ardent Health's net margin of 2.09%. Ardent Health's return on equity of 13.85% beat Viemed Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ardent Health	2.09%	13.85%	4.48%
Viemed Healthcare	5.20%	10.52%	7.60%

74.2% of Viemed Healthcare shares are held by institutional investors. 1.9% of Ardent Health shares are held by company insiders. Comparatively, 20.6% of Viemed Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Ardent Health presently has a consensus price target of $14.04, suggesting a potential upside of 32.47%. Given Ardent Health's stronger consensus rating and higher probable upside, equities analysts clearly believe Ardent Health is more favorable than Viemed Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ardent Health	2 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.36
Viemed Healthcare	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Ardent Health has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market. Comparatively, Viemed Healthcare has a beta of 1.1, suggesting that its stock price is 10% more volatile than the broader market.

Ardent Health has higher revenue and earnings than Viemed Healthcare. Ardent Health is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ardent Health	$6.32B	0.24	$135.81M	$0.95	11.16
Viemed Healthcare	$270.28M	1.67	$14.93M	$0.37	31.81

In the previous week, Viemed Healthcare had 1 more articles in the media than Ardent Health. MarketBeat recorded 2 mentions for Viemed Healthcare and 1 mentions for Ardent Health. Ardent Health's average media sentiment score of 1.01 beat Viemed Healthcare's score of 0.39 indicating that Ardent Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ardent Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Viemed Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Ardent Health and Viemed Healthcare tied by winning 8 of the 16 factors compared between the two stocks.

Get Viemed Healthcare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

VMD vs. The Competition

Export

Metric	Viemed Healthcare	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$451.23M	$8.81B	$7.06B	$12.20B
Dividend Yield	N/A	2.53%	2.67%	9.41%
P/E Ratio	31.81	18.51	27.14	23.63
Price / Sales	1.67	7.41	582.30	111.98
Price / Cash	10.22	18.17	49.81	58.78
Price / Book	3.11	3.19	10.28	6.01
Net Income	$14.93M	$230.22M	$3.60B	$331.99M
7 Day Performance	-3.13%	21.66%	-1.27%	-0.63%
1 Month Performance	1.20%	18.29%	-1.67%	-3.04%
1 Year Performance	92.32%	-4.55%	18.25%	13.30%

Viemed Healthcare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
VMD Viemed Healthcare	2.2599 of 5 stars	$11.77 +0.9%	N/A	+92.3%	$451.23M	$270.28M	31.81	1,382	News Coverage
WGS GeneDx	4.2112 of 5 stars	$61.65 +1.6%	$87.43 +41.8%	-26.0%	$1.80B	$427.54M	N/A	1,300	Trending News
TDOC Teladoc Health	1.2262 of 5 stars	$9.71 +0.6%	$7.73 -20.3%	+6.7%	$1.74B	$2.51B	N/A	5,600	Upcoming Earnings Analyst Forecast
FTRE Fortrea	1.9516 of 5 stars	$17.91 +1.0%	$17.75 -0.9%	+187.1%	$1.68B	$2.72B	N/A	14,300	Upcoming Earnings Analyst Downgrade
INNV InnovAge	1.7874 of 5 stars	$11.84 +6.9%	$7.00 -40.9%	+201.0%	$1.50B	$949.17M	N/A	2,440	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:VMD) was last updated on 7/26/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Viemed Healthcare (VMD) Competitors

VMD vs. WGS, TDOC, FTRE, INNV, and ARDT

How does Viemed Healthcare compare to GeneDx?

Summary

How does Viemed Healthcare compare to Teladoc Health?

Summary

How does Viemed Healthcare compare to Fortrea?

Summary

How does Viemed Healthcare compare to InnovAge?

Summary

How does Viemed Healthcare compare to Ardent Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VMD vs. The Competition

Viemed Healthcare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Viemed Healthcare (VMD) Competitors

VMD vs. WGS, TDOC, FTRE, INNV, and ARDT

How does Viemed Healthcare compare to GeneDx?

Which has more volatility and risk, VMD or WGS?

Do insiders and institutionals believe in VMD or WGS?

Do analysts prefer VMD or WGS?

Is VMD or WGS more profitable?

Does the media favor VMD or WGS?

Which has preferable valuation & earnings, VMD or WGS?

Summary

How does Viemed Healthcare compare to Teladoc Health?

Which has preferable earnings and valuation, VMD or TDOC?

Does the media prefer VMD or TDOC?

Do analysts recommend VMD or TDOC?

Do institutionals & insiders have more ownership in VMD or TDOC?

Is VMD or TDOC more profitable?

Which has more volatility & risk, VMD or TDOC?

Summary

How does Viemed Healthcare compare to Fortrea?

Is FTRE or VMD more profitable?

Do analysts rate FTRE or VMD?

Do institutionals and insiders hold more shares of FTRE or VMD?

Which has stronger valuation and earnings, FTRE or VMD?

Which has more volatility & risk, FTRE or VMD?

Does the media prefer FTRE or VMD?

Summary

How does Viemed Healthcare compare to InnovAge?

Do analysts recommend INNV or VMD?

Which has stronger earnings & valuation, INNV or VMD?

Which has more volatility & risk, INNV or VMD?

Does the media refer more to INNV or VMD?

Do institutionals and insiders hold more shares of INNV or VMD?

Is INNV or VMD more profitable?

Summary

How does Viemed Healthcare compare to Ardent Health?

Is ARDT or VMD more profitable?

Do insiders and institutionals have more ownership in ARDT or VMD?

Do analysts rate ARDT or VMD?

Which has more volatility and risk, ARDT or VMD?

Which has higher earnings and valuation, ARDT or VMD?

Does the media refer more to ARDT or VMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VMD vs. The Competition

Viemed Healthcare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools